2003 Fiscal Year Final Research Report Summary
Detection of downstream target gene for E2A-HLF oncogenic chimeric transcription factor
| Project/Area Number |
14570769
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Pediatrics
|
|---|
| Research Institution | Dokkyo University School of Medicine |
|---|
Principal Investigator |
KUROSAWA Hidemitsu Dokkyo University School of Medicine, Associate professor, 医学部, 助教授 (10205239)
|
|---|
| Project Period (FY) |
2002 – 2003
|
| Keywords | E2A-HLF / Annexin II / Transcription factor / Target gene |
|---|
| Research Abstract |
In pro-B cell acute lymphoblastic leukemia (ALL), expression of the E2A-HLF fusion gene as a result of the t(17;19)(q22;p13) is associated with poor prognosis, hypercalcemia, and hemorrhagic complications. We previously reported that the E2A-HLF fusion protein protects interleukin (IL)-3-dependent lymphoid cells from apoptosis caused by cytokine starvation. Here, we report that annexin II, a surface phospholipid-binding protein and one of the proposed causes of the hemorrhagic c9mplications of acute promyelocytic leukemia (APL), is also implicated in t(17;19)^+ ALL. Annexin II was expressed at high levels in APL cells and in each of four t(17;19)^+ leukemia cell lines, and annexin II expression was I. induced by enforced expression of E2A-HLF in leukemia cells. In IL-3-dependent cells, we found that annexin II expression was regulated by IL-3 mainly by Ras pathways, including Ras/phosphatidylinositol 3-kinase pathways. Moreover, E2A-HLF increased annexin II expression in 11-3-depe ndent cells in the absence of the cytokine. These findings indicate that E2A-HLF induces annexin II by substituting for cytokines that activate downstream pathways of Ras. These findings indicate that annexin II is a downstream target of the E2A-HLF oncoprotein. However, surface expression levels of annexin II among leukemia cells with t(17;19) varied in a manner that suggests that annexin II plays a role in the hypercalcemia or leukemic invasion rather than in the coagulopathy associated with this type of ALL.
|
